{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T12:12:05Z","timestamp":1777378325194,"version":"3.51.4"},"reference-count":0,"publisher":"SAGE Publications","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Research and Human Retroviruses"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:p>\n                    Little is known about immunologic reconstitution in children on highly active antiretroviral treatment (HAART) during very long-term periods. A retrospective study was carried out to assess the effectiveness and development of metabolic disorders after very long-term periods on HAART in HIV-infected children with severe immunodeficiency. We included 55 children who were stratified into three groups according to %CD4\n                    <jats:sup>+<\/jats:sup>\n                    pre-HAART and rate of immunologic recovery: (1) S1-Rec: CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u22645% at baseline and slow immunologic recovery; (2) S2-Rec: CD4\n                    <jats:sup>+<\/jats:sup>\n                    5\u201315% at baseline and slow immunologic recovery; (3) R-Rec: CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u226415% at baseline and rapid immunologic recovery (reference group). An adequate immune recovery after 8 years on HAART was achieved by only 25% of children. S1-Rec never achieved a mean of CD4\n                    <jats:sup>+<\/jats:sup>\n                    \u226525% after 8 years on HAART. All children had a significant increase in plasma cholesterol levels during the first 2 years. Afterward, cholesterol levels reached a plateau and remained stable until year 8 of follow-up. Higher rates of lipodystrophy were found in the R-Rec group [14 (100%)] than in the S1-Rec group [9\/19 (47.4%)] or the S2-Rec group [13\/20 (65%)] at the end of the study (\n                    <jats:italic toggle=\"yes\">p<\/jats:italic>\n                    = 0.006). Overall, having a low nadir of CD4\n                    <jats:sup>+<\/jats:sup>\n                    hindered immune reconstitution; however, children with rapid immunologic recovery showed a higher prevalence of the lipodystrophy syndrome.\n                  <\/jats:p>","DOI":"10.1089\/aid.2008.0037","type":"journal-article","created":{"date-parts":[[2008,11,19]],"date-time":"2008-11-19T09:29:16Z","timestamp":1227086956000},"page":"1477-1484","source":"Crossref","is-referenced-by-count":9,"title":["Immunological Recovery and Metabolic Disorders in Severe Immunodeficiency HIV Type 1-Infected Children on Highly Active Antiretroviral Therapy"],"prefix":"10.1177","volume":"24","author":[{"given":"Salvador","family":"Resino","sequence":"first","affiliation":[{"name":"Laboratorio de Inmuno-Biolog\u00eda Molecular, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n,\u201d Madrid, Spain."},{"name":"Instituto de Salud Carlos III, Majadahonda, Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dariela","family":"Micheloud","sequence":"additional","affiliation":[{"name":"Instituto de Salud Carlos III, Majadahonda, Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Larr\u00fa","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmuno-Biolog\u00eda Molecular, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n,\u201d Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Bell\u00f3n","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmuno-Biolog\u00eda Molecular, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n,\u201d Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Antonio","family":"L\u00e9on","sequence":"additional","affiliation":[{"name":"Pediatr\u00eda-Infecciosas, Hospital Universitario \u201cVirgen de Roc\u00edo,\u201d Seville, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa","family":"Resino","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmuno-Biolog\u00eda Molecular, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n,\u201d Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Isabel","family":"De Jos\u00e9","sequence":"additional","affiliation":[{"name":"Inmuno-Pediatr\u00eda, Hospital Universitario \u201cLa Paz,\u201d Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Dolores Gurbindo","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[{"name":"Inmuno-Pediatr\u00eda, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n,\u201d Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Jos\u00e9","family":"Mellado","sequence":"additional","affiliation":[{"name":"Pediatr\u00eda-Infecciosas, Hospital Universitario \u201cCarlos III,\u201d Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Guillen","sequence":"additional","affiliation":[{"name":"Pediatr\u00eda, Hospital Universitario de Get\u00e1fe, Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Tomas","family":"Ramos","sequence":"additional","affiliation":[{"name":"Pediatr\u00eda, Hospital Universitario de Get\u00e1fe, Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. \u00c1ngeles","family":"Mu\u00f1oz-Fern\u00e1ndez","sequence":"additional","affiliation":[{"name":"Laboratorio de Inmuno-Biolog\u00eda Molecular, Hospital General Universitario \u201cGregorio Mara\u00f1\u00f3n,\u201d Madrid, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on Behalf of the Spanish Group of Paediatric HIV Infection","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2008,12,1]]},"container-title":["AIDS Research and Human Retroviruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2008.0037","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/aid.2008.0037","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:10:43Z","timestamp":1777367443000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/aid.2008.0037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["10.1089\/aid.2008.0037"],"URL":"https:\/\/doi.org\/10.1089\/aid.2008.0037","relation":{},"ISSN":["0889-2229","1931-8405"],"issn-type":[{"value":"0889-2229","type":"print"},{"value":"1931-8405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}